You can buy or sell I-MAB and other stocks, options, ETFs, and crypto commission-free!
I-Mab operates as a clinical stage biopharmaceutical company. It engages in the development and commercialization of biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. Read More The company was founded by Jingwu Zhang Zang on June 30, 2016 and is headquartered in Pudong, China.
52 Week High
52 Week Low
— per share
Expected Nov 10, Pre-Market